Reports on the potential of RNA interference (RNAi). Harnessing of RNAi for target identification and validation and developing a possible powerful new therapeutic class; Adoption of RNAi technology in laboratories around the world; Higher probability of success for RNAi therapeutics; Focus of many companies towards hepatitis virus; Attraction of investors and venture capitalists as an obstacle; RNAi's place among the major technology platforms.